|
Delayed
London S.E.
16:35:03 01/12/2020 GMT
|
5-day change | 1st Jan Change | ||
| 0.7500 GBX | -25.00% |
|
-.--% | -78.57% |
| Market Cap | 36.29M 32.35M 29.77M 27.08M 50.82M 3.44B 51.71M 359M 141M 1.8B 136M 133M 5.69B | P/E 2018 |
-1.52x | P/E 2019 | -0.66x |
|---|---|---|---|---|---|
| Enterprise Value | 204M 182M 167M 152M 286M 19.35B 291M 2.02B 796M 10.15B 766M 750M 31.99B | EV / Sales 2018 |
2.53x | EV / Sales 2019 | 2.27x |
| Free-Float |
26.49% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -25.00% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/20 | Buy | Founder | 1,148,784,403 | 17.1060% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -25.00% | -.--% | - | - | 54.86M | |
| +2.83% | +8.10% | +63.42% | +123.50% | 1,133B | |
| +3.81% | +5.40% | +39.47% | +74.91% | 621B | |
| +0.14% | +0.60% | +23.25% | +95.03% | 503B | |
| +0.03% | +5.72% | +39.64% | +64.06% | 379B | |
| -1.76% | -0.09% | +68.04% | +43.41% | 370B | |
| +1.58% | +5.07% | +23.26% | +51.98% | 292B | |
| +2.90% | +5.53% | +4.06% | +24.45% | 262B | |
| +2.04% | +4.97% | +48.53% | +60.42% | 237B | |
| +2.36% | +2.38% | +26.68% | +102.04% | 190B | |
| Average | -1.34% | +2.89% | +37.37% | +71.09% | 398.8B | |
| Weighted average by Cap. | +1.31% | +3.73% | +43.30% | +82.74% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 84.3M 75.14M 69.14M 62.9M 118M 7.99B 120M 835M 329M 4.19B 316M 310M 13.21B | 79.76M 71.1M 65.42M 59.52M 112M 7.56B 114M 790M 311M 3.97B 299M 293M 12.5B |
| Net income | -18.6M -16.58M -15.25M -13.88M -26.04M -1.76B -26.49M -184M -72.49M -925M -69.77M -68.3M -2.91B | -20.04M -17.86M -16.44M -14.95M -28.06M -1.9B -28.55M -198M -78.11M -996M -75.19M -73.6M -3.14B |
| Net Debt | 185M 165M 152M 138M 259M 17.52B 263M 1.83B 721M 9.19B 693M 679M 28.97B | 168M 150M 138M 125M 235M 15.91B 239M 1.66B 654M 8.34B 630M 616M 26.3B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- CTI Stock
Select your edition
All financial news and data tailored to specific country editions
